Computational Molecular Biology 2024, Vol.14, No.3, 106-114 http://bioscipublisher.com/index.php/cmb 112 genomic datasets, facilitating data sharing and collaborative efforts among researchers (Yukselen et al., 2020). These platforms are designed to be user-friendly and accessible, with features such as graphical user interfaces and modular process designs that simplify the creation and execution of complex data processing pipelines. By leveraging modern big data technologies, these open-source platforms empower researchers to manage, analyze, and integrate diverse genomic data, driving advancements in precision medicine and personalized healthcare (Vadapalli et al., 2022). 8 Concluding Remarks The integration of artificial intelligence (AI) and machine learning (ML) into genomic research has significantly transformed the field, enabling the analysis of large, complex datasets with unprecedented accuracy and efficiency. ML methods, including supervised, semi-supervised, and unsupervised learning, have been effectively applied to genome sequencing data, aiding in the annotation of sequence elements and the analysis of epigenetic, proteomic, and metabolomic data. Deep learning models have shown superior performance in specific genomic tasks, such as predicting gene expression levels and identifying genomic elements like promoters and enhancers. These models are particularly effective in handling high-dimensional data, which is common in genomics. AI and ML approaches are crucial in precision medicine, where they help integrate genetic, environmental, and lifestyle factors to diagnose and treat diseases more accurately. These methods facilitate the analysis of whole genome and exome sequencing data, contributing to personalized treatment plans. Bibliometric analyses reveal that AI applications in biotechnology and applied microbiology are rapidly evolving, with significant contributions from global institutions. Key research areas include deep learning, prediction models, and systems biology. The future of AI in genomic research is promising, with several potential advancements on the horizon. The integration of deep learning with multi-scale and multimodal data analysis is expected to drive significant advancements in precision medicine, enabling more comprehensive and accurate models of disease progression and treatment. Future research will likely focus on integrating AI-generated predictive knowledge with traditional causal concepts in molecular genetics. This integration is essential for developing robust scientific understanding and effective policies in genomic medicine. As AI applications in biology continue to grow, there will be a need for improved standards and practices in publishing and experimental design. This will ensure the reliability and reproducibility of AI-driven research findings. To fully harness the potential of AI in genomic research, the following recommendations are proposed. Encourage collaboration between AI experts, biologists, and medical researchers to develop more sophisticated models and algorithms that can address complex biological questions. Emphasize the importance of high-quality data and robust pre-processing techniques to avoid the pitfalls associated with poor data quality, which can lead to inaccurate models and predictions. Address ethical concerns related to the use of AI in genomics, particularly regarding data privacy, consent, and the potential for bias in AI models. Developing ethical guidelines and frameworks will be crucial for the responsible use of AI in this field. Continued investment in AI research and development is essential to drive innovation and maintain the momentum in genomic research. This includes funding for both basic and applied research, as well as support for training and education in AI and genomics. By following these recommendations, the field of genomic research can continue to benefit from the transformative potential of AI, leading to more accurate, efficient, and personalized approaches to understanding and treating genetic diseases. Acknowledgments Cuixi Academy of Biotechnology provided critical resources that facilitated this research, and we express our gratitude.We also would like to thank two anonymous peer reviewers for their careful review and valuable comments. Conflict of Interest Disclosure The authors affirm that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==